Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study

Howes, O, Bose, S, Turkheimer, F, Valli, I, Egerton, A, Stahl, D, Valmaggia, L, Allen, P +2 more·2011·Molecular Psychiatry
DOI 10.1038/mp.2011.20

Cited by (292)

Items 201–292 of 292

  1. Positive symptom phenotypes appear progressively in “EDiPS”, a new animal model of the schizophrenia prodrome
    Alice E. Petty, Xiaoying Cui, Asad Amanat Ali, Zilong Du, Sunil Srivastav, James P. Kesby, Deniz Kirik, Oliver David Howes, Darryl Walter Eyles · 2021 · Scientific Reports
  2. Presynaptic Dopaminergic Function: Implications for Understanding Treatment Response in Psychosis
    I. Bonoldi, O. Howes · 2014 · CNS Drugs
  3. Possible Biomarkers and Contributing Factors of Psychosis: a Review
    Monu Yadav, Naresh Kumar, Anil Kumar, Deepak Kumar Jindal, Mini Dahiya · 2021 · Current Pharmacology Reports
  4. Neuroimaging studies in people at clinical high risk for psychosis
    George Gifford, Robert Ali McCutcheon, Philip K. McGuire · 2020 · Elsevier eBooks
  5. Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk
    Cathy Davies, Matthijs Geert Bossong, Daniel Martins, Robin Paul Wilson, Elizabeth Appiah‐Kusi, Grace Blest‐Hopley, Paul Allen, Fernando O. Zelaya, David J. Lythgoe, Michael John Brammer et al. · 2023 · Schizophrenia Bulletin Open
  6. Is treatment-resistance in psychiatric disorders a trap for polypharmacy?
    Miroslava Jašović‐Gašić · 2015 · PubMed
  7. GABA Dysfunction in Schizophrenia: The GABAA Receptor as a Potential Therapeutic Target
    Brandon L. M. Crotchett, Seth D. Reighard, Henry A. Nasrallah · 2025 · Biomarkers in Neuropsychiatry
  8. Delusions: Understanding the Un-understandable
    Peter J. McKenna · 2017
  9. Striatal GDNF Neurons Chemoattract RET-Positive Dopamine Axons at Seven Times Farther Distance Than Medium Spiny Neurons
    Ana Montaño-Rodriguez, Tabea Schorling, Jaan‐Olle Andressoo · 2024 · Cells
  10. Personalisierte Medizin in der Psychiatrie und Psychotherapie
    Nikolaos Koutsouleris, Stephan Ruhrmann, Peter Falkai, Wolfgang Maier · 2013 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  11. Translating neuroimaging findings into psychiatric practice
    Thomas James Reilly, Philip K. McGuire · 2013 · The British Journal of Psychiatry
  12. Radiomic Analysis of Striatal [18F]FDOPA PET Imaging in Patients with Psychosis for the Identification of Antipsychotic Response
    Astrid Schiulaz, Giovanna Nordio, Alessio Giacomel, Rubaida Easmin, Andrea Bettinelli, Pierluigi Selvaggi, Steven Williams, Federico Turkheimer, Sameer Jauhar, Oliver David Howes et al. · 2025 · Molecular Imaging and Biology
  13. The concept of psychotic arousal and its relevance to abnormal subjective experiences in schizophrenia. A hypothesis for the formation of primary delusions
    Maria M. Margariti, Ilias I. Vlachos · 2022 · Medical Hypotheses
  14. Positron Emission Tomography Assessments of Phosphodiesterase 10A in Patients With Schizophrenia
    Manabu Kubota, Keisuke Takahata, Kiwamu Matsuoka, Yasunori Sano, Yasuharu Yamamoto, Kenji Tagai, Ryosuke Tarumi, Hisaomi Suzuki, Shin Kurose, Shinichiro Nakajima et al. · 2022 · Schizophrenia Bulletin
  15. Reversal learning in those with early psychosis features contingency-dependent changes in loss response and learning
    Andrea Baker, Shuichi Suetani, Peter Cosgrove, Dan J. Siskind, Graham K. Murray, James G. Scott, James P. Kesby · 2023 · Cognitive Neuropsychiatry
  16. Maternal Nutritional Deficiencies and Schizophrenia
    Darryl Walter Eyles, Angela J. Dean · 2015 · Handbook of behavioral neuroscience
  17. Dexamphetamine influences funneling illusion based on psychometric score
    Faiz Mohammed Kassim, J. H. Mark Lim, Matthew A. Albrecht, Mathew Thomas Martin-Iverson · 2023 · Human Psychopharmacology Clinical and Experimental
  18. Activating the dorsomedial and ventral midbrain projections to the striatum differentially impairs goal-directed action in male mice
    Kyna‐Anne Conn, Simin Zou, Joyosmita Das, S Alexander, Thomas H.J. Burne, James P. Kesby · 2023 · Neuropharmacology
  19. Sollen bei Prodromalstadien der Schizophrenie Antipsychotika zur Psychoseprävention eingesetzt werden? Pro
    Martin Lambert, Christoph Ulrich Correll · 2015 · Der Nervenarzt
  20. Suppression of the dorsomedial striatum impairs reversal learning in response to probabilistic uncertainty and disrupts corticostriatal function in mice
    Kyna‐Anne Conn, Joyosmita Das, S Alexander, Thomas H.J. Burne, James P. Kesby · 2025 · Neuropharmacology
  21. The Association Between Childhood Impaired Motor Development and Adolescent Psychotic Experiences
    Pauline C. M. Hamers, Diandra C. Bouter, Sieds Dieleman, Witte J.G. Hoogendijk, Nina H. Grootendorst–van Mil · 2025 · Developmental Psychobiology
  22. Imagerie cérébrale et déconstruction de l’esprit
    Renaud de Beaurepaire · 2016 · L Évolution Psychiatrique
  23. Dopamine manipulations modulate paranoid social inferences in healthy people
    Joseph M Barnby, Vaughan Bell, Quinton Deeley, Mitul Ashok Mehta · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  24. Individual and combined effects of Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) on striato-cortical connectivity in the human brain
    Matthew B. Wall, Tom P. Freeman, Chandni Hindocha, Lysia Demetriou, Natalie Ertl, Abigail M. Freeman, A. Jones, Will Lawn, Rebecca Anne Pope, Claire Mokrysz et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Transcriptional and neurochemical signatures of cerebral blood flow alterations in schizophrenia and the clinical high-risk state for psychosis
    Samuel Knight, Leyla Abbasova, Yashar Zeighami, Justine Y. Hansen, Daniel Martins, Fernando O. Zelaya, Ottavia Dipasquale, T. Liu, D. Shin, Matthijs Geert Bossong et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  26. Refining mechanistic models of hallucinations for enhanced translatability
    Justin Buck, Kiyohito Iigaya, Guillermo Horga · 2025 · Translational Psychiatry
  27. The utility of PET imaging in the diagnosis and management of psychosis: a brief review
    Grant Harding Rigney, Cyrus Ayubcha, Thomas J. Werner, Abass A. Alavi, Mona-Elisabeth R. Revheim · 2021 · Clinical and Translational Imaging
  28. Using Nonhuman Primate Models to Reverse-Engineer Prefrontal Circuit Failure Underlying Cognitive Deficits in Schizophrenia
    Mathew V. Chafee · 2022 · Current topics in behavioral neurosciences
  29. Elucidating gut microbiota–hippocampus interactions in emerging psychosis: A new perspective for the development of early interventions for memory impairments
    Galya Clara Iseli, Sarah Ulrich, André Schmidt · 2023 · Frontiers in Psychiatry
  30. A comprehensive update on genetic inheritance, epigenetic factors, associated pathology, and recent therapeutic intervention by gene therapy in schizophrenia
    R. R., Harshit Devtalla, Karishma Rana, S. Panda, Arushi Agrawal, Shreya Kadyan, Divya Jindal, Pranav Pancham, Deepshikha Yadav, N. Jha et al. · 2023 · Chemical Biology and Drug Design
  31. The Anatomy of Delusion
    Georges Naasan · 2016 · Elsevier eBooks
  32. Predicting Outcome in Schizophrenia: Neuroimaging and Clinical Assessments
    Nancy C. Andreasen, Thomas Nickl‐Jockschat · 2020 · Springer eBooks
  33. Dopamine and Response to Antipsychotic Medication
    Chukwuma Ntephe, Arsime Demjaha · 2020 · Springer eBooks
  34. The neuromediator mechanisms of the cognitive deficit in schizophrenia
    Zinaida I. Storozheva, Anna V. Kirenskaya, Andrey T. Proshin · 2015 · Neurochemical Journal
  35. Erratum zu: Sollen bei Prodromalstadien der Schizophrenie Antipsychotika zur Psychoseprävention eingesetzt werden? Pro
    Martin Lambert, Christoph Ulrich Correll · 2016 · Der Nervenarzt
  36. Mesocorticolimbic circuit mechanisms underlying the effects of ketamine on dopamine: a translational imaging study
    Michelle Kokkinou, Elaine E. Irvine, David R. Bonsall, Sridhar Natesan, Lisa A. Wells, Mark Smith, Justyna A. Glegola, Eleanor J. Paul, Kyoko Tossell, Mattia Veronese et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  37. The dopaminergic basis of negative symptoms in schizophrenia: an addendum
    Ana Weidenauer, I. Dajić, N. Praschak-rieder, Matthaeus Willeit · 2024 · Molecular Psychiatry
  38. Effect of the TAAR1 Partial Agonist Ralmitaront on Presynaptic Dopamine Synthesis Capacity Measured Using [ 18 F]DOPA PET in Naïve and Cocaine-Treated Mice
    David R. Bonsall, Michelle Kokkinou, Els F. Halff, Grazia Rutigliano, Sac-Pham Tang, Mattia Veronese, Elaine E. Irvine, Dominic J. Withers, Lisa A. Wells, Sridhar Natesan et al. · 2024 · Molecular Imaging
  39. Halved Dose of Antipsychotics Versus High-Dose Antipsychotic Therapy for Relapse in Patients with Schizophrenia Receiving High-Dose Antipsychotic Therapy: A Randomized Single-Blind Trial
    Ryota Ataniya, Takeshi Koike, Atsuko Inamoto · 2025 · International Journal of Molecular Sciences
  40. Dopamine synthesis capacity in patients with remitted psychosis: correlates and one year outcome on relapse
    Christy Lai Ming Hui, Charlie Cheuk Lam Wong, Nicole Cai Lin Yang, E. G. Choi, Priscilla Wing Man Hui, Eric Lui, J Tao, Elise Chun‐Ning Ho, Yi Nam Suen, Sirong Chen et al. · 2026 · European Archives of Psychiatry and Clinical Neuroscience
  41. SN/VTA neuromelanin signal is associated with subclinical paranoia irrespective of familial risk for psychosis
    Rami Hamati, Nour Kanaa, Bianca Chidiac, Synthia Guimond, Clifford Cassidy, Lauri J. Tuominen · 2026 · Schizophrenia
  42. Static and dynamic alterations of local brain activity in schizophrenia and associations with clinical symptoms and cognitive function
    Shuzhe Wang, Peiwen Ren, Chenghao Lu, Xiaofei Zhang, Yeqing Dong, Feng Liu, Shen Li, Jie Li · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  43. Schizophrenia
    Bart A. Ellenbroek, Jiun Youn · 2016 · Elsevier eBooks
  44. Stati mentali a rischio di psicosi: identificazione e strategie attuali di trattamento [translation of “At-risk mental state for psychosis: identification and current treatment approaches” by Dr. Giulia Rioli]
    Andrew David Thompson, Steven Marwaha, Matthew R. Broome · 2016 · BJPsych Advances
  45. Correlation Between Intellectual Function and Relapse of Schizophrenia Regarding Dose Reduction in Patients Undergoing High-Dose Antipsychotic Therapy
    Ryota Ataniya, MIKIRO SAITO, Tadashi Takahashi · 2017 · Juntendō Igaku/Juntendo igaku
  46. Models of Schizophrenia. A Selective Review of Genetic, Neuropharmacological, Cognitive, and Social Approaches
    Megan C. Ichinose, Sohee Park · 2019 · Elsevier eBooks
  47. Not all stress is created equal: Acute, not ambient stress, impairs learning in high schizotypes
    Emma E. Walter, Francesca Fernandez, Emma Barkus · 2021 · PsyCh Journal
  48. Molecular and topographic mapping of antipsychotic effects: a meta-analysis of postsynaptic density proteins in animal models with translational implications
    G. De Simone, M. De Prisco, Vincenzo Oliva, L. Vellucci, M. Ciccarelli, B. Mazza, G. Fico, M. Fornaro, F. Iasevoli, E. Vieta et al. · 2025 · Molecular Psychiatry
  49. Dopamine and the Biology and Course of Treatment Resistance
    Arsime Demjaha, Oliver David Howes · 2014 · Springer eBooks
  50. Brain PET Poster Sessions PP01-M01 to PP02-N07
    D. Lange, Isabel Martinez Tejada, M. xiong, B. Hillebrand, M. Noergaard, S. Baerentzen, Vladimir Shalgunov, M. M. Herth, C. Svarer, M. Palner · 2019 · Journal of Cerebral Blood Flow & Metabolism
  51. Molecular Imaging
    Simon Červenka, Lars Farde · 2020 · Springer eBooks
  52. Magnetic Resonance and Molecular Imaging in Psychiatry
    Oliver David Howes · 2015 · Elsevier eBooks
  53. Studying biomarkers in populations at genetic and clinical high risk for psychosis
    Mariken Beatrijs de Koning · 2013
  54. Effective Connectivity and Dopaminergic Function of Fronto-Striato-Thalamic Circuitry in First-Episode Psychosis, Established Schizophrenia, and Healthy Controls
    Kristina Sabaroedin, Adeel Razi, Sidhant Chopra, Nancy Tran, Andrii Pozaruk, Zhaolin Chen, Amy Finlay, Barnaby Nelson, Kelly Allott, Mario Álvarez‐Jiménez et al. · 2021 · medRxiv
  55. Enhanced dopamine in prodromal schizophrenia (EDiPS): a new animal model of relevance to schizophrenia
    Alice E. Petty · 2019 · The University of Queensland
  56. An Egg & Chicken Paradox: Are changes in the Basal ganglia volume the reason for or the result of Schizophrenia?
    Ümit Haluk Yeşilkaya, Meltem Sen, Neslihan Yüzbaşıoğlu, Kadriye Betül Pençe, Nesrin Karamustafalıoğlu · 2023
  57. Dopamine and schizophrenia from bench to bedside: Discovery of a striatal co-expression risk gene set that predicts in vivo measures of striatal function
    Leonardo Sportelli, Daniel Paul Eisenberg, Roberta Passiatore, Enrico D’Ambrosio, Linda Antonella Antonucci, Qiang Chen, Jasmine Czarapata, Aaron L. Goldman, Michael A. Gregory, Kira Griffiths et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Investigating Dopaminergic Abnormalities in Psychosis with Normative Modelling and Multisite Molecular Neuroimaging
    Alessio Giacomel, Daniel Martins, Giovanna Nordio, Rubaida Easmin, Oliver David Howes, Pierluigi Selvaggi, Steven Williams, Federico Turkheimer, Marius de Groot, Ottavia Dipasquale et al. · 2023 · medRxiv
  59. A single dose of cannabidiol modulates the coupling between hippocampal glutamate and learning-related prefrontal activation in individuals at Clinical High Risk of Psychosis
    Yiling Shi, Cathy Davies, Robin Paul Wilson, Elizabeth Appiah‐Kusi, David J. Lythgoe, Gemma Modinos, Sagnik Bhattacharyya · 2024 · medRxiv
  60. Epidemiological and biological mechanisms of cannabis as cause of psychosis
    Rebecca Kuepper · 2012
  61. Aspectos metodológicos para la evaluación de sistemas de tomografía por emisión de positrones empleando técnicas Montecarlo, protocolos estandarizados y diferentes trazadores
    Mario Cañadas Castro · 2012
  62. Is dopamine still the key to treating schizophrenia?
    Steve Titmarsh · 2013 · Progress in Neurology and Psychiatry
  63. psychosisdysfunction in people with prodromal or first-episode
    D Howes, Valeria Mondelli, Heather Taylor, Marta Di Forti, Philip K. McGuire, Robin M. Murray, Oliver Tiago Reis Marques, Stefania Bonaccorso, Fiona Gaughran, Anna Kolliakou · 2012
  64. Authors' reply
    Oliver David Howes, Siobhan Gee, David M. Taylor · 2013 · The British Journal of Psychiatry
  65. Brain imaging and the deconstruction of mind
    Renaud de Beaurepaire · 2016 · L Évolution Psychiatrique
  66. Altered Neural Synchronies Underlying Cognitive Deficits in a Transgenic Mouse Model of Huntington’s Disease
    Yoon H. Cho, Yannick Jeantet · 2015 · Springer eBooks
  67. of imaging studies function in schizophrenia: systematic review and meta-analysis Alterations in cortical and extrastriatal subcortical dopamine
    Joseph P. Kambeitz, Anissa Abi‐Dargham, Shitij Kapur, Oliver David Howes · 2014
  68. The Effects of Atypical Antipsychotics on Implicit Reward Learning in Schizophrenia
    Lisa Bradford · 2015 · QSpace (Queen's University Library)
  69. translating research evidence into clinical utility Third-generation neuroimaging in early schizophrenia:
    Stefan Borgwardt, Paolo Fusar‐Poli · 2012
  70. Do antipsychotic drugs improve working memory impairment caused by increased dopamine release during relapse phases of schizophrenia?
    Ryota Ataniya · 2018 · Asia Pacific Journal of Clinical Trials Nervous System Diseases
  71. Neuroimaging and Antipsychotics
    Antonio Vita, Florian Schlagenhauf, Stefano Barlati, Andreas Heinz · 2019 · Springer eBooks
  72. Structural and functional neuroimaging of schizophrenia
    Andreea Oliviana Diaconescu, Sandra Iglesias, Klaas Enno Stephan · 2020
  73. P.503 Positive symptom phenotypes appear progressively in "enhanced dopamine in prodromal schizophrenia", a new animal model of the schizophrenia prodrome
    Alice E. Petty, Xiaoying Cui, Asad Amanat Ali, Oliver David Howes, Darryl Walter Eyles · 2020 · European Neuropsychopharmacology
  74. Induced pluripotent stem cells in psychiatry: a critical review
    Alejandro De Los Angeles, Kristen Brennand, Nicola Hall, Michael B. Fernando, Paul J. Harrison, Brady J. Maher, Daniel R. Weinberger, Elizabeth M. Tunbridge · 2021
  75. Psychotic Disorders
    James G. Scott, Bjorn Burgher · 2020 · The Encyclopedia of Child and Adolescent Development
  76. A volumetric dilemma: Large basal ganglia in medication-naive first episode psychosis
    Ümit Haluk Yeşilkaya, Melten Sen, Neslihan Yüzbaşıoğlu, Kadriye Betül Pençe, Nesrin Karamustafalıoğlu · 2022 · Research Square
  77. Halved dose of antipsychotics versus symptomatic treatment for relapse in patients with schizophrenia receiving high-dose antipsychotic therapy: a randomized single-blind trial
    Ryota Ataniya, Ken Koike, Atsuko Inamoto · 2022 · Research Square
  78. An insight into the acute effects of cannabidiol on human brain function and their relationship with the brain expression of its molecular targets: a neuroimaging meta-regression analysis
    Brandon Gunasekera, Cathy Davies, Grace Blest‐Hopley, Robin Paul Wilson, Geraldo F. Busatto, José Alexandre S. Crippa, Fábio Duran, Antônio Waldo Zuardi, Mattia Veronese, Joaquim Raduà et al. · 2022 · Research Square
  79. Enlarged basal ganglia in drug-naïve patients with first-episode psychosis immediately upon symptom onset
    Ümit Haluk Yeşilkaya · 2024 · Dusunen Adam The Journal of Psychiatry and Neurological Sciences
  80. Bridging the Phenomenology of Prodromal Psychosis with Its Underlying Neurobiological Mechanisms
    Scott Schobel · 2024 · Springer eBooks
  81. The Role of the Immune System in Creating Depression, Post-traumatic-Stress-Disorder, and Psychosis
    Jill Leslie Littrell · 2024 · Integrated science
  82. Association of the DRD and OXT Genetic Polymorphisms With Schizophrenia in a Chinese Population
    Jingjing Li, Wen Bi, Mengqiu Xiong, Lubanga Nasifu, Lingyun Zhang, Chengbin Zhu, Bangshun He · 2025 · The Journal of Nervous and Mental Disease
  83. Excess GDNF associates with a subtype of schizophrenia with enhanced dopamine and increased prefrontal dysfunction
    Isabel Runneberger, Daniel R. Garton, Peyman Choopanian, Ana Montaño-Rodriguez, Mehdi Mirzaie, Funda Orhan, Vladislav Yakimov, Joanna Moussiopoulou, Vilma Iivanainen, Soophie Olfat et al. · 2025 · medRxiv
  84. A single dose of cannabidiol modulates the relationship between hippocampal glutamate and learning-related prefrontal activation in individuals at Clinical High Risk of Psychosis
    Yiling Shi, Cathy Davies, Robin Paul Wilson, Elizabeth Appiah‐Kusi, David J. Lythgoe, Gemma Modinos, Sagnik Bhattacharyya · 2025 · Psychiatry Research Neuroimaging
  85. Structural and functional cerebral changes in patients with schizophrenia and genetic risk-allele carriers
    Joseph P. Kambeitz · 2014 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
  86. Connecting the dots : new perspectives on stress and psychosis
    Johan Lataster · 2012
  87. A narrative review of the methodology deployed in PET studies investigating low activity levels of radiopharmaceuticals
    Daniela Ribeiro, William Hallett, Stephen M. Husbands · 2026 · Radiography
  88. Dynamical circular inference in the general population and the psychosis spectrum : insights from perceptual decision making
    Pantelis Leptourgos · 2018 · theses.fr (ABES)
  89. Local chemoarchitecture explains widespread lower cortical thickness associated with clinical high risk for psychosis
    Xi Yang, Ingrid Agartz, Ole A. Andreassen, Peter Bachman, Inmaculada Baeza, Cali Bartholomeusz, Stefan Borgwardt, Sunah Choi, Tiziano Colibazzi, Rebecca E. Cooper et al. · 2026 · Molecular Psychiatry
  90. Etude de l'implication du système dopaminergique nigrostrié dans les comportements motivés et l'alcoolodépendance
    Raphaël Goutaudier · 2022
  91. From brain bioenergetics to hypothalamic glucoregulation: A shared-systems hypothesis for intrinsic dysglycemia in schizophrenia
    Laurie Hamel, S x E rgio L. Pereira, Zeyu Yang, Ameth N. Garrido, Sri Mahavir Agarwal, Tony K.T. Lam, Margaret K. Hahn · 2026 · Reviews in Endocrine and Metabolic Disorders
  92. Beyond Classical Reward Circuits: Dorsal Striatum Proteomic Alterations in an Adolescent Phencyclidine-Induced Mouse Model of Schizophrenia and Nicotine Use
    Thainá Pereira de Souza, Andrés Rodríguez-Vega, Ana Carolina Dutra-Tavares, Keila A. Semeão, Cláudio Carneiro Filgueiras, Anderson Ribeiro‐Carvalho, Alex C. Manhães, Yael Abreu‐Villaça · 2026 · International Journal of Molecular Sciences